查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1781182

兽医循环系统学的全球市场，动物的类别，各产品，各适应症，各终端用户，各流通管道，各地区，机会，预测，2018年～2032年

Global Veterinary Cardiology Market Assessment, By Animal Type, By Product, By Indication, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Markets & Data | 英文 233 Pages | 商品交期: 3-5个工作天内

价格

全球兽医心臟病学市场预计将从2024年的30.2亿美元成长到2032年的52.7亿美元，2025年至2032年的复合年增长率为7.21%。全球兽医心臟病学市场持续成长，主要原因是宠物主人数量的增加、动物心臟健康意识的增强以及对先进诊断和治疗方案的需求不断增长。随着伴侣动物寿命的延长以及主人对宠物健康的日益重视，对心臟影像、监测和治疗介入等专业服务的需求也日益增长。

便携式心电图设备、远端心电图和微创手术等技术进步正在帮助提高兽医心臟护理的可及性和准确性。兽医基础设施、宠物保险覆盖率和宠物支出的增加也进一步推动了市场成长。预计市场环境将保持强劲，其中北美占据最大市场份额，亚太地区由于宠物拥有量的增加和兽医护理的改善，将成为规模最大、增长最快的市场。市场面临的两大挑战是设备和营运成本高昂、训练有素的兽医放射科医生等人力资源有限，以及各地区监管路径分散且不一致。此外，犬心臟疾病（尤其是扩张型心肌病变和二尖瓣疾病）的持续发病率正在推动对心臟病学服务的需求。

例如，根据塔夫茨大学卡明斯兽医学院 2024 年 9 月的报告，超过 10% 接受兽医检查的动物出现心血管疾病的迹象。这些疾病往往会随着时间的推移而恶化，而且通常很难以及早发现，这凸显了兽医心臟病学市场对精准诊断工具和长期药物治疗日益增长的需求。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 美国的关税的影响

第4章 摘要整理

第5章 全球兽医循环系统学市场展望，2018年～2032年

  • 市场规模分析与预测
    • 各金额
  • 市场占有率分析与预测
    • 动物的类别
      • 宠物
      • 家畜
    • 各产品
      • 医药品
      • 诊断
    • 各适应症
      • 充血性心臟衰竭
      • 心肌疾病
      • 心律不整
      • 其他
    • 各终端用户
      • 动物医院和诊疗所
      • 学术调查机关
      • 其他
    • 各流通管道
      • 医院药局
      • 零售药局
      • 电子商务
    • 各地区
      • 北美
      • 欧洲
      • 亚太地区
      • 南美
      • 中东及非洲
    • 各企业市场占有率分析(前五名公司以及其他- 各金额，2024年)
  • 2024年市场地图分析
    • 动物的类别
    • 各产品
    • 各适应症
    • 各终端用户
    • 各流通管道
    • 各地区

第6章 北美的兽医循环系统学市场展望，2018年～2032年

  • 市场规模分析与预测
    • 各金额
  • 市场占有率分析与预测
    • 动物的类别
      • 宠物
      • 家畜
    • 各产品
      • 医药品
      • 诊断
    • 各适应症
      • 充血性心臟衰竭
      • 心肌疾病
      • 心律不整
      • 其他
    • 各终端用户
      • 动物医院和诊疗所
      • 学术调查机关
      • 其他
    • 各流通管道
      • 医院药局
      • 零售药局
      • 电子商务
    • 各国占有率
      • 美国
      • 加拿大
      • 墨西哥
  • 各国市场评估
    • 美国的兽医循环系统学市场展望，2018年～2032年预测
      • 市场规模分析与预测
      • 市场占有率分析与预测
    • 加拿大
    • 墨西哥

所有部门市市场均涵盖所有地区和国家。

第7章 欧洲的兽医循环系统学市场展望，2018年～2032年

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 土耳其
  • 波兰

第8章 亚太地区的兽医循环系统学市场展望，2018年～2032年

  • 印度
  • 中国
  • 日本
  • 澳洲
  • 越南
  • 韩国
  • 印尼
  • 菲律宾

第9章 南美的兽医循环系统学市场展望，2018年～2032年

  • 巴西
  • 阿根廷

第10章 中东·非洲的兽医循环系统学市场展望，2018年～2032年

  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非

第11章 价值链分析

第12章 波特的五力分析

第13章 大环境分析

第14章 价格分析

第15章 市场动态

  • 推动市场要素
  • 市场课题

第16章 市场趋势与发展

第17章 临床试验的形势

第18章 法规结构和革新

第19章 案例研究

第20章 竞争情形

  • 前五名市场领导公司的竞争矩阵
  • 前五名企业的SWOT分析
  • 前10名市场主要企业的形势
    • Dextronix, Inc
      • 公司概要
      • 主要经营团队
      • 产品和服务
      • 财务状况(报告那样)
      • 主要市场的着重和地理存在感
      • 最近的趋势/合作/伙伴关係/合併和收购
    • IDEXX Laboratories, Inc.
    • Contec Medical Systems Co. Ltd
    • Antech Diagnostics, Inc.
    • Bionet Co., Ltd
    • Eickemeyer Veterinary Equipment Limited
    • Narang Medical Limited
    • Shenzhen Comen Medical Instruments Co., Ltd
    • iWorx Systems Inc
    • New Gen Medical Systems Inc.

以上公司非基于市场份额排序，并且可能会根据研究过程中可用的信息而变化。

第21章 策略性建议

第22章 关于调查公司·免责声明

Product Code: MX13840

Global veterinary cardiology market is projected to witness a CAGR of 7.21% during the forecast period 2025-2032, growing from USD 3.02 billion in 2024 to USD 5.27 billion in 2032. The global market for veterinary cardiology continues to grow, mainly fueled by rising pet ownership, increased awareness of animal heart health, and the growing demand for advanced diagnostic and treatment options. As companion animals live longer and pet owners become more invested in their pets' well-being, the need for specialized services such as cardiac imaging, monitoring, and therapeutic interventions is increasing.

Increases in technology, such as portable ECG devices, tele-cardiology and procedures that are less invasive in nature, are helping to increase the accessibility and accuracy of veterinary based cardiac care. Increases in veterinary infrastructure, pet insurance coverage and pet expenditures are also bolstering growth in the market further. The market environment is expected to remain strong going forward with North America having the largest market share and Asia-Pacific becoming the largest and fastest growing market as a result of increased pet adoption and improved veterinary care. The two biggest challenges facing the market are high equipment and operational costs, limited human resources pertaining to trained veterinary radiologists, and fragmented and inconsistent regulatory pathways in different regions. In addition, the continued incidence of heart conditions in dogs, specifically dilated cardiomyopathy and mitral valve disease, increases demand for cardiology services.

For instance, according to a September 2024 report from Tufts University, Cummings School of Veterinary Medicine, over 10% of animals examined by veterinarians show signs of cardiovascular disease. These conditions tend to worsen over time and are often difficult to detect in early stages, which highlights the increasing need for accurate diagnostic tools and long-term pharmaceutical treatment in the veterinary cardiology market.

Technological Advancement Driving Growth in the Veterinary Cardiology Market

Technological advancements are having a big impact on the expansion of the veterinary cardiology market. Recent advancements in veterinary cardiology includes the development of digital electrocardiograms (ECGs), high-resolution imaging systems, and portable ultrasound and diagnostic devices. These technological advancements have considerably improved the rate and accuracy of a cardiac assessment in the animal population. It has enabled veterinary professionals to diagnose chronic degenerative heart disease earlier and treat the heart condition quickly and accurately. Telemedicine is also contributing to this trend by providing remote access to veterinary cardiology specialists by regions that often can't provide access to channel veterinary cardiology services. The availability of user-friendly pet-specific medical devices is contributing to compliance and monitoring in treatment of pets with cardiac disease. As technology has continued to improve, it is making cardiac care more accessible, precise, efficient, and affordable and thus opening the door to greater demand worldwide and new skill sets for veterinary cardiology practices.

For instance, in September 2024, the Atlantic Veterinary College at the University of Prince Edward Island launched a clinical trial to treat cardiac tumors in dogs. The study explores the use of propranolol, a drug commonly used for similar conditions in children, marking a step forward in veterinary cardiac oncology. In another instance, in February 2025, Golden Hour launched STAT telemedicine Services for the veterinary industry. This service aims to improve access to real-time cardiology consultations, especially in areas with limited specialist availability.

Rising Pet Ownership Driving Adoption in Veterinary Cardiology Market

Rising levels of pet ownership in combination with the increasing humanization of companion animals will continue to affect the growth of the veterinary cardiology market. More households are adopting pets and seeing them as a family member. With this humanization of pets comes higher expectations around the veterinary care that pets receive, which has evolved into more advanced and specialized care, including cardiac diagnostics and treatment. This emotional bond is resulting in increased healthcare spending, as pet owners are becoming more proactive in seeking preventive care and paying attention to symptoms of heart-related diseases. The rise in pet adoption and pet owners, especially the younger generations has also expanded the total addressable market for pet services. Therefore, opportunities are consistently creating demand for cardiology solutions within veterinary practices, and driving clinics to invest in equipment, who perform cardiology, expertise, and innovative cardiovascular technologies to accommodate evolving pet parent consumer expectations.

For instance, data from the 2024 American Veterinary Medical Association (AVMA) Pet Ownership and Demographic Sourcebook revealed that 45.5% of United States households own dogs and 32.1% own cats, totaling approximately 89.7 million dogs and 73.8 million cats nationwide.

Pharmaceuticals Segment Dominates the Veterinary Cardiology Market

The pharmaceuticals segment plays a key role in the veterinary cardiology market. It includes drugs like pimobendan, spironolactone, and benazepril. These medicines help manage heart failure and other heart conditions in pets. They improve heart function and reduce symptoms. Most are easy to give and work well for long-term use. Pet owners are now more aware of early treatment options. This increases demand for heart medications. Clinics use these drugs regularly for cardiac care. New formulations, like oral solutions, are also being developed. These innovations support better dosing and compliance. As heart issues in pets rise, this segment will likely keep growing.

For instance, in April 2024, the U.S. Food and Drug Administration (FDA) approved the first generic version of pimobendan for managing congestive heart failure in dogs. This approval is expected to improve accessibility and reduce treatment costs, offering veterinarians and pet owners a more affordable option for long-term cardiac care.

North America Dominates the Market

North America maintains a leading position in the global veterinary cardiology market due to its advanced veterinary healthcare infrastructure, high standards of clinical practice, and strong demand for specialized services. The reason behind the dominance of this region is high percentage of pet ownership, increased awareness of cardiovascular diseases in their companion animals, and pet owners are generally more willing to invest in advanced veterinary care. North America has major corporate players, established diagnostic networks, and keen interest in innovative technologies advances impacting the field of veterinary cardiology, in particular imaging and ECG and telemedicine. Furthermore, robust regulatory policies, an ample supply of veterinary specialists, and ongoing investment in research and development are also unique characteristics of North America with both being positive indicators for continued veterinary cardiology growth and innovation. All of these factors synergistically contribute to North America being able to continue advancing the industry as well as continue to spur global trends and directions in veterinary cardiology.

For instance, in November 2024, Boehringer Ingelheim Vetmedica GmbH launched VETMEDIN Solution, the first FDA-approved oral solution for treating congestive heart failure in dogs. This new formulation allows for easier dosing and improved treatment compliance. Its introduction aligns with rising demand for advanced cardiac care in emerging veterinary markets.

Impact of U.S. Tariffs on Veterinary Cardiology Market

U.S. tariffs continue to affect the veterinary cardiology market. Import duties on medical devices and components drive up clinic expenses. Products like stethoscopes, monitors, and imaging systems are harder to afford. Clinics may reduce the frequency of cardiac screenings. Some avoid purchasing new equipment altogether. This slows down adoption of new technologies.

Clients may face higher fees for advanced diagnostics. Smaller practices feel the strain most. Their limited budgets make it harder to absorb rising costs. To adapt, many clinics seek cost-effective or refurbished devices. Others are renegotiating supplier contracts. Some turn to bulk purchasing or group buying networks. These steps help manage expenses without compromising care quality. However, the long-term impact may limit innovation and accessibility in veterinary cardiology across the globe.

Key Players Landscape and Outlook

Key players in the global veterinary cardiology market are focusing on innovation to stay competitive. IDEXX Laboratories, Inc.., Dextronix, Inc., and Antech Diagnostics, Inc. are incorporating artificial intelligence, cloud computing ECG systems, and wireless telemetry into their offerings. Bionet Co., Ltd. Contec Medical Systems Co., Ltd., and Shenzhen Comen Medical Instruments Co., Ltd. are working on portable and cost-effective cardiac monitors. These monitors are very useful for large-hospital settings and small clinics. Eickemeyer Veterinary Equipment Limited, Narang Medical Limited, iWorx Systems Inc., and New Gen Medical Systems Inc. are enhancing their products through ongoing research and development. Many of the firms are pursuing partnerships with veterinary clinics, universities, and other research institutions increase the discoveries they make and hopes of improving diagnostic accuracy or treatment outcomes. Innovation, accessibility, and reaching more countries are centered around tackling advancement in animal cardiac services to meet increasing requests for these services.

For instance, in June 2025, Boehringer Ingelheim Vetmedica GmbH and Eko Health Inc. partnered to improve heart murmur detection in dogs. The collaboration uses Eko's AI-enabled stethoscope technology to help vets detect cardiac issues earlier and more accurately during routine exams.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Veterinary Cardiology Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Animal Type
      • 5.2.1.1. Companion Animals
      • 5.2.1.2. Livestock Animals
    • 5.2.2. By Product
      • 5.2.2.1. Pharmaceuticals
      • 5.2.2.2. Diagnostics
    • 5.2.3. By Indication
      • 5.2.3.1. Congestive Heart Failure
      • 5.2.3.2. Myocardial (Heart Muscle) Disease
      • 5.2.3.3. Arrhythmias
      • 5.2.3.4. Others
    • 5.2.4. By End-user
      • 5.2.4.1. Veterinary Hospitals and Clinics
      • 5.2.4.2. Academic and Research Institutions
      • 5.2.4.3. Others
    • 5.2.5. By Distribution Channel
      • 5.2.5.1. Hospital Pharmacy
      • 5.2.5.2. Retail Pharmacy
      • 5.2.5.3. E-Commerce
    • 5.2.6. By Region
      • 5.2.6.1. North America
      • 5.2.6.2. Europe
      • 5.2.6.3. Asia-Pacific
      • 5.2.6.4. South America
      • 5.2.6.5. Middle East and Africa
    • 5.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Animal Type
    • 5.3.2. By Product
    • 5.3.3. By Indication
    • 5.3.4. By End-user
    • 5.3.5. By Distribution Channel
    • 5.3.6. By Region

6. North America Veterinary Cardiology Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Animal Type
      • 6.2.1.1. Companion Animals
      • 6.2.1.2. Livestock Animals
    • 6.2.2. By Product
      • 6.2.2.1. Pharmaceuticals
      • 6.2.2.2. Diagnostics
    • 6.2.3. By Indication
      • 6.2.3.1. Congestive Heart Failure
      • 6.2.3.2. Myocardial (Heart Muscle) Disease
      • 6.2.3.3. Arrhythmias
      • 6.2.3.4. Others
    • 6.2.4. By End-user
      • 6.2.4.1. Veterinary Hospitals and Clinics
      • 6.2.4.2. Academic and Research Institutions
      • 6.2.4.3. Others
    • 6.2.5. By Distribution Channel
      • 6.2.5.1. Hospital Pharmacy
      • 6.2.5.2. Retail Pharmacy
      • 6.2.5.3. E-Commerce
    • 6.2.6. By Country Share
      • 6.2.6.1. United States
      • 6.2.6.2. Canada
      • 6.2.6.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Veterinary Cardiology Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Animal Type
          • 6.3.1.2.1.1. Companion Animals
          • 6.3.1.2.1.2. Livestock Animals
        • 6.3.1.2.2. By Product
          • 6.3.1.2.2.1. Pharmaceuticals
          • 6.3.1.2.2.2. Diagnostics
        • 6.3.1.2.3. By Indication
          • 6.3.1.2.3.1. Congestive Heart Failure
          • 6.3.1.2.3.2. Myocardial (Heart Muscle) Disease
          • 6.3.1.2.3.3. Arrhythmias
          • 6.3.1.2.3.4. Others
        • 6.3.1.2.4. By End-user
          • 6.3.1.2.4.1. Veterinary Hospitals and Clinics
          • 6.3.1.2.4.2. Academic and Research Institutions
          • 6.3.1.2.4.3. Others
        • 6.3.1.2.5. By Distribution Channel
          • 6.3.1.2.5.1. Hospital Pharmacy
          • 6.3.1.2.5.2. Retail Pharmacy
          • 6.3.1.2.5.3. E-Commerce
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Veterinary Cardiology Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Veterinary Cardiology Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Veterinary Cardiology Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Veterinary Cardiology Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Clinical Trial Landscape

18. Regulatory Framework and Innovation

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Dextronix, Inc
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. IDEXX Laboratories, Inc.
    • 20.3.3. Contec Medical Systems Co. Ltd
    • 20.3.4. Antech Diagnostics, Inc.
    • 20.3.5. Bionet Co., Ltd
    • 20.3.6. Eickemeyer Veterinary Equipment Limited
    • 20.3.7. Narang Medical Limited
    • 20.3.8. Shenzhen Comen Medical Instruments Co., Ltd
    • 20.3.9. iWorx Systems Inc
    • 20.3.10. New Gen Medical Systems Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 3. Global Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 4. Global Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 5. Global Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 7. Global Veterinary Cardiology Market Share (%), By Region, 2018-2032F
  • Figure 8. North America Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 9. North America Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 10. North America Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 11. North America Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 12. North America Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 13. North America Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 14. North America Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 15. United States Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. United States Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 17. United States Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 18. United States Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 19. United States Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 20. United States Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 21. Canada Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 22. Canada Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 23. Canada Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 24. Canada Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 25. Canada Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 26. Canada Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 27. Mexico Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 28. Mexico Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 29. Mexico Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 30. Mexico Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 31. Mexico Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 32. Mexico Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 33. Europe Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 34. Europe Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 35. Europe Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 36. Europe Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 37. Europe Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 38. Europe Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 39. Europe Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 40. Germany Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. Germany Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 42. Germany Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 43. Germany Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 44. Germany Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 45. Germany Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 46. France Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 47. France Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 48. France Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 49. France Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 50. France Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 51. France Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 52. Italy Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Italy Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 54. Italy Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 55. Italy Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 56. Italy Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 57. Italy Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 58. United Kingdom Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 59. United Kingdom Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 60. United Kingdom Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 61. United Kingdom Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 62. United Kingdom Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 63. United Kingdom Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 64. Russia Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Russia Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 66. Russia Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 67. Russia Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 68. Russia Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 69. Russia Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 70. Netherlands Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 71. Netherlands Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 72. Netherlands Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 73. Netherlands Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 74. Netherlands Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 75. Netherlands Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 76. Spain Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 77. Spain Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 78. Spain Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 79. Spain Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 80. Spain Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 81. Spain Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 82. Turkey Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. Turkey Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 84. Turkey Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 85. Turkey Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 86. Turkey Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 87. Turkey Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 88. Poland Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 89. Poland Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 90. Poland Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 91. Poland Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 92. Poland Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 93. Poland Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 94. Asia-Pacific Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Asia-Pacific Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 96. Asia-Pacific Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 97. Asia-Pacific Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 98. Asia-Pacific Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 99. Asia-Pacific Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 100. Asia-Pacific Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 101. India Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 103. India Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 104. India Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 105. India Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 106. India Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 107. China Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 108. China Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 109. China Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 110. China Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 111. China Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 112. China Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 113. Japan Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 114. Japan Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 115. Japan Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 116. Japan Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 117. Japan Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 118. Japan Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 119. Australia Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Australia Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 121. Australia Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 122. Australia Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 123. Australia Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 124. Australia Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 125. Vietnam Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 126. Vietnam Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 127. Vietnam Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 128. Vietnam Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 129. Vietnam Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 130. Vietnam Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 131. South Korea Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. South Korea Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 133. South Korea Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 134. South Korea Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 135. South Korea Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 136. South Korea Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 137. Indonesia Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 138. Indonesia Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 139. Indonesia Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 140. Indonesia Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 141. Indonesia Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 142. Indonesia Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 143. Philippines Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 144. Philippines Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 145. Philippines Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 146. Philippines Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 147. Philippines Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 148. Philippines Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 149. South America Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 150. South America Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 151. South America Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 152. South America Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 153. South America Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 154. South America Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 155. South America Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 156. Brazil Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 157. Brazil Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 158. Brazil Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 159. Brazil Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 160. Brazil Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 161. Brazil Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 162. Argentina Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 163. Argentina Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 164. Argentina Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 165. Argentina Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 166. Argentina Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 167. Argentina Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 168. Middle East & Africa Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 169. Middle East & Africa Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 170. Middle East & Africa Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 171. Middle East & Africa Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 172. Middle East & Africa Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 173. Middle East & Africa Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 174. Middle East & Africa Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 175. Saudi Arabia Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 176. Saudi Arabia Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 177. Saudi Arabia Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 178. Saudi Arabia Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 179. Saudi Arabia Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 180. Saudi Arabia Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 181. UAE Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 182. UAE Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 183. UAE Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 184. UAE Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 185. UAE Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 186. UAE Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 187. South Africa Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 188. South Africa Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 189. South Africa Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 190. South Africa Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 191. South Africa Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 192. South Africa Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 193. By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 194. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 195. By Indication Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 197. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 198. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024